(December 21, 2020, 9:49 AM EST) -- NEW YORK — The Securities and Exchange Commission sued a biotechnology company and its CEO in New York federal court on Dec. 17, alleging that the defendants violated federal securities laws...
Biotech Company, CEO Named In SEC Suit Over Alleged COVID-19 Blood Test Device
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login